Regulatory Strategy
Regulatory Strategy is a deliberate, forward-looking plan of action that integrates scientific, clinical, manufacturing, and nonmarket considerations to shape and navigate the regulatory environment governing the development, approval, and lifecycle management of biomedical products, thereby aligning organizational objectives with evolving statutory, administrative, and policy requirements.
517
Publications
26.8K
Citations
1.3K
Authors
656
Institutions
Publications per year
2017–2026
164
517
Contested Boundaries in Policy-Relevant Science
Sheila Jasanoff · Social Studies of Science · 1987 · 803 citations
1–5 of 517
1.3K
6
h-index
4
h-index
United States Food and Drug Administration, United States
4 publications · 190 citations
4
h-index
4
h-index
4
h-index
1–5 of 1.3K
656
United States Food and Drug Administration
Silver Spring, United States
14 h-index
45 publications
1.6K citations
University of Sussex
Brighton, United Kingdom
10 h-index
15 publications
405 citations
Center for Drug Evaluation and Research
Silver Spring, United States
9 h-index
19 publications
1K citations
University of Oxford
Oxford, United Kingdom
8 h-index
9 publications
831 citations
Utrecht University
Utrecht, The Netherlands
7 h-index
17 publications
479 citations
University of Michigan
Ann Arbor, United States
7 h-index
8 publications
408 citations
KU Leuven
Leuven, Belgium
6 h-index
12 publications
406 citations
Arizona State University
Tempe, United States
6 h-index
9 publications
505 citations
1–8 of 656
Repository · 23 publications · 773 citations
16
h-index
12 publications · 347 citations
11
h-index
10 publications · 358 citations
10
h-index
Repository · 10 publications · 311 citations
10
h-index
6 publications · 243 citations
6
h-index
1–5